Makale
Tam Makale
Uluslararası
2020
Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Cilt 26 · Sayı 7 · ss. 1791–1794 · 01.10.2020
Özet
Introduction
Anahtar kelimeler
ACUTE KIDNEY INJURY
immune thrombocytopenic purpura
Immune checkpoint inhibitors
atezolizumab
Atıf için künye
YILMAZ, A., Mirili, C., Bilici, M., & TEKİN, S. B. (2020). Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 26(7), 1791–1794. https://doi.org/10.1177/1078155220913081
BibTeX
@article{yilmaz2020-228396,
author = {YILMAZ, Ali and Mirili, Cem and Bilici, Mehmet and TEKİN, Salim Başol},
title = {Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia},
journal = {JOURNAL OF ONCOLOGY PHARMACY PRACTICE},
year = {2020},
volume = {26},
number = {7},
pages = {1791--1794},
issn = {1078-1552},
doi = {10.1177/1078155220913081},
url = {https://akademik.atauni.edu.tr/yayinlar/228396-possible-atezolizumab-associated-acute-kidney-injury-and-immune-thrombocytopenia}
}